← Back to Patent Explorer
US4483929A Expired / Lapsed US ⏱️ 0.0 years remaining

Liposomes with glycolipid-linked antibodies

Assignee: Liposome Technology Inc
•
Filing: 1982-05-03
•
Granted: 1984-11-20
•
Expires: 2002-05-03
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Lipid vesicles, labelled with encapsulated reporter compositions and bound to antibodies comprise a new class of immunoreagent, useful in immunoassays for ligands.

Inventors

  • 👤 Frank C. Szoka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 18:22
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/585; G01N33/586; Y; Y10; Y10S; Y10S435/00; Y10S435/966; Y10S436/00; Y10S436/80; Y10S436/803; Y10S436/819; Y10S436/828; Y10S436/829

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 65 words
An immunoreactive liposome reagent for use in the determination of a chemical compound capable of entering into an immunospecific reaction with a known antibody, said reagent comprising a suspension of liposomes containing reporter molecules, and a surface array of molecules of such antibody attached to the liposomes through glycolipid molecules anchored in the liposomes and linked to the antibody molecules by a diimidazole coupling agent.
Claim 2
Dependent Claim 65 words
An immunoreactive liposome reagent for use in the determination of a chemical compound capable of entering into an immunospecific reaction with a known antibody, said reagent comprising a suspension of liposomes containing reporter molecules, and a surface array of molecules of such antibody attached to the liposomes through glycolipid molecules anchored in the liposomes and linked to the antibody molecules by a diimidazole coupling agent.
Claim 3
Dependent Claim 18 words
The reagent of claim 1, wherein the glycolipid is a melibionamide and the diimidazole coupling agent is 1,1-carbonyldiimidazole.
Claim 4
Dependent Claim 10 words
The reagent of claim 2, wherein the melibionamide is tetradecylmelibionamide.
Claim 5
Independent Claim 66 words
A method of producing an immunoreactive liposome reagent having an array of surface-bound antibody molecules, said method comprising providing a glycolipid, linking such antibody molecules covalently to molecules of the glycolipid, in an aqueous medium, with a diimidazole coupling agent, and mixing the resultant antibody-glycolipid couple with liposomes in an aqueous medium to produce binding of the antibody to the liposome surface through the linked glycolipid.
Claim 6
Independent Claim 66 words
A method of producing an immunoreactive liposome reagent having an array of surface-bound antibody molecules, said method comprising providing a glycolipid, linking such antibody molecules covalently to molecules of the glycolipid, in an aqueous medium, with a diimidazole coupling agent, and mixing the resultant antibody-glycolipid couple with liposomes in an aqueous medium to produce binding of the antibody to the liposome surface through the linked glycolipid.
Claim 7
Dependent Claim 12 words
The method of claim 4, wherein the glycolipid provided is a melibionamide.
Claim 8
Dependent Claim 11 words
The method of claim 5, wherein the melibionamide provided is tetradecylmelibionamide.
Claim 9
Dependent Claim 10 words
The method of claim 5, wherein the diimidazole is 1,1-carbonyldiimidazole.
Claim 10
Dependent Claim 16 words
The method of claim 5, wherein said linking is performed in the absence of a detergent.
Claim 11
Dependent Claim 26 words
The method of claim 8, wherein said mixing is also performed in the absence of a detergent to produce a liposome reagent free of contaminating detergent.

References Cited (Backward Citations)

US3995018A Cited
US3995018B1 Cited
US3995018B2 Cited
US4200436A Cited
US4235792A Cited
US4193983A Cited
US4255411A Cited
US4342739A Cited
US4372745A Cited
US4376110A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-11-20 1988-05-21 1988-11-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-11-20 1992-05-21 1992-11-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-11-20 1996-05-21 1996-11-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag